Reply to Lambros et al

Affiliations

¹ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, USA.
³ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Free article

Comment

Zhenya Tang et al. Mod Pathol. 2018 Mar.

Free article

. 2018 Mar;31(3):541-542.

doi: 10.1038/modpathol.2017.192.

¹ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, USA.
³ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Comment on

Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma.
Tang Z, Zhang J, Lu X, Wang W, Chen H, Robinson MK, Cheng J, Tang G, Medeiros LJ. Tang Z, et al. Mod Pathol. 2018 Feb;31(2):307-312. doi: 10.1038/modpathol.2017.109. Epub 2017 Sep 15. Mod Pathol. 2018. PMID: 28914263
The rarity of concomitant genetic alterations in lung cancer.
Lambros L, Guibourg B, Le Flahec G, Uguen A. Lambros L, et al. Mod Pathol. 2018 Mar;31(3):539-540. doi: 10.1038/modpathol.2017.176. Mod Pathol. 2018. PMID: 29515241 No abstract available.